InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,460.00
(
0.95%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.57
(
0.14%
)
Bitcoin
60,885.91
(
-1.84%
)
Post# of 27549
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Katfish

Send PM Follow Ignore
Followers 78
Posts 24631
Boards Moderated 1
Alias Born 09/08/2000

Katfish

Member Level

Re: None

Thursday, 06/13/2024 7:37:33 AM

Thursday, June 13, 2024 7:37:33 AM

Post# of 27549
LGVN - 2.48/2.49 Up from 1.81

Watching Longeveron; Zacks Small-Cap Research Issues $15.10 Price Valuation; Says Longeveron Is Focusing On Using Its Primary Treatment, Lomecel-B, To Fight A Rare Pediatric Heart Birth Defect That Devastates Families; Announced The Completion Of An Encouraging Meeting With Investigators Involved In The Ongoing Trial Of Lomecel-B For The Treatment Of HLHS
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up